Global Retirement Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.6K | Buy |
+978
| New | +$47.6K | ﹤0.01% | 1800 |
|
|
2024
Q4 | $38.7K | Sell |
984
-1,291
| -57% | -$50.8K | ﹤0.01% | 1749 |
|
|
2024
Q3 | $107K | Hold |
2,275
| – | – | ﹤0.01% | 1207 |
|
|
2024
Q2 | $123K | Hold |
2,275
| – | – | ﹤0.01% | 1093 |
|
|
2024
Q1 | $155K | Hold |
2,275
| – | – | 0.01% | 892 |
|
|
2023
Q4 | $144K | Buy |
2,275
+725
| +47% | +$46K | 0.01% | 884 |
|
|
2023
Q3 | $64.5K | Hold |
1,550
| – | – | ﹤0.01% | 1140 |
|
|
2023
Q2 | $87K | Hold |
1,550
| – | – | ﹤0.01% | 1006 |
|
|
2023
Q1 | $76.2K | Buy |
1,550
+1,500
| +3,000% | +$73.8K | ﹤0.01% | 1037 |
|
|
2022
Q4 | $2.03K | Hold |
50
| – | – | ﹤0.01% | 2358 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 2076 |
|
|
2022
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 2034 |
|
|
2022
Q1 | $3K | Sell |
50
-107
| -68% | -$6.42K | ﹤0.01% | 2032 |
|
|
2021
Q4 | $12K | Sell |
157
-250
| -61% | -$19.1K | 0.01% | 143 |
|
|
2021
Q3 | $46K | Sell |
407
-100
| -20% | -$11.3K | ﹤0.01% | 884 |
|
|
2021
Q2 | $82K | Hold |
507
| – | – | 0.01% | 688 |
|
|
2021
Q1 | $62K | Buy |
507
+354
| +231% | +$43.3K | 0.01% | 704 |
|
|
2020
Q4 | $23K | Buy |
+153
| New | +$23K | ﹤0.01% | 981 |
|